The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies—back to the future!-Reference-Cited by-同舟云学术

The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies—back to the future!

Published:2020-03 Issue:1 Volume:33 Page:101150
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Kazandjian Dickran,Dew Alexander,Hill Elizabeth

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference76 articles.

1. Multiple myeloma epidemiology and survival: a unique malignancy;Kazandjian;Semin Oncol,2016

2. Cancer statistics;Siegel;CA A Cancer J Clin,2019

3. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016;Cowan;JAMA Oncol,2018

4. A look backward and forward in the regulatory and treatment history of multiple myeloma: approval of novel-novel agents, new drug development, and longer patient survival;Kazandjian;Semin Oncol,2016

5. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives;Critical Reviews in Oncology/Hematology;2023-07

2. Multiple Myeloma;Advances in Molecular Pathology;2022-11

3. Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma;Frontiers in Endocrinology;2022-03-25

4. Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches;Journal of Clinical Medicine;2021-04-23

5. Melphalan Flufenamide: a Peptide-Drug Conjugate for the Treatment of Multiple Myeloma;Oncology & Haematology;2021